Global and United States Cardiovascular and Cerebrovascular API Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.

Market Analysis and Insights: Global and United States Cardiovascular and Cerebrovascular API Market
This report focuses on global and United States Cardiovascular and Cerebrovascular API market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Cardiovascular and Cerebrovascular API market size is estimated to be worth US$ 3162.7 million in 2022 and is forecast to a readjusted size of US$ 3710.9 million by 2028 with a CAGR of 2.7% during the review period. Fully considering the economic change by this health crisis, by Type, Sartans Cardiovascular and Cerebrovascular API accounting for % of the Cardiovascular and Cerebrovascular API global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Oral Drugs was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

China is the main production area of cardiovascular and cerebrovascular raw materials, with a market share of more than 65%, followed by India and Europe.

The key manufacturers are Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, MSN Life Sciences etc. Zhejiang Huahai Pharmaceutical Co., Ltd. is the largest producer of cardiovascular and cerebrovascular raw materials in China region market and global market, accounting for more than 10%.

Global Cardiovascular and Cerebrovascular API Scope and Market Size
Cardiovascular and Cerebrovascular API market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cardiovascular and Cerebrovascular API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Cardiovascular and Cerebrovascular API market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Cardiovascular and Cerebrovascular API market is segmented into
    Sartans Cardiovascular and Cerebrovascular API
    Statins Cardiovascular and Cerebrovascular API
    Puri Cardiovascular and Cerebrovascular API

Segment by Application, the Cardiovascular and Cerebrovascular API market is segmented into
    Oral Drugs
    Injection Drugs

Regional and Country-level Analysis
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Cardiovascular and Cerebrovascular API Market Share Analysis
Cardiovascular and Cerebrovascular API market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Cardiovascular and Cerebrovascular API business, the date to enter into the Cardiovascular and Cerebrovascular API market, Cardiovascular and Cerebrovascular API product introduction, recent developments, etc.

The major vendors covered:
    Zhuhai Rundu Pharmaceutical
    Ningbo Menovo Pharmaceutical
    Zhejiang Huahai Pharmaceutical
    Zhejiang Tianyu Pharmaceutical
    Zhejiang Hisun Pharmaceutical
    Zhejiang Lepu Pharmaceutical
    Zhejiang Jiangbei Pharmaceutical
    DR.Reddy
    Glenmerk
    Cipla
    MSN Life Sciences

 1 Study Coverage
    1.1 Cardiovascular and Cerebrovascular API Product Introduction
    1.2 Global Cardiovascular and Cerebrovascular API Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Cardiovascular and Cerebrovascular API Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Cardiovascular and Cerebrovascular API Sales in Volume for the Year 2017-2028
    1.3 United States Cardiovascular and Cerebrovascular API Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Cardiovascular and Cerebrovascular API Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Cardiovascular and Cerebrovascular API Sales in Volume for the Year 2017-2028
    1.4 Cardiovascular and Cerebrovascular API Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Cardiovascular and Cerebrovascular API in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Cardiovascular and Cerebrovascular API Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Cardiovascular and Cerebrovascular API Market Dynamics
        1.5.1 Cardiovascular and Cerebrovascular API Industry Trends
        1.5.2 Cardiovascular and Cerebrovascular API Market Drivers
        1.5.3 Cardiovascular and Cerebrovascular API Market Challenges
        1.5.4 Cardiovascular and Cerebrovascular API Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Cardiovascular and Cerebrovascular API Market Segment by Type
        2.1.1 Sartans Cardiovascular and Cerebrovascular API
        2.1.2 Statins Cardiovascular and Cerebrovascular API
        2.1.3 Puri Cardiovascular and Cerebrovascular API
    2.2 Global Cardiovascular and Cerebrovascular API Market Size by Type
        2.2.1 Global Cardiovascular and Cerebrovascular API Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Cardiovascular and Cerebrovascular API Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Cardiovascular and Cerebrovascular API Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Cardiovascular and Cerebrovascular API Market Size by Type
        2.3.1 United States Cardiovascular and Cerebrovascular API Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Cardiovascular and Cerebrovascular API Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Cardiovascular and Cerebrovascular API Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Cardiovascular and Cerebrovascular API Market Segment by Application
        3.1.1 Oral Drugs
        3.1.2 Injection Drugs
    3.2 Global Cardiovascular and Cerebrovascular API Market Size by Application
        3.2.1 Global Cardiovascular and Cerebrovascular API Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Cardiovascular and Cerebrovascular API Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Cardiovascular and Cerebrovascular API Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Cardiovascular and Cerebrovascular API Market Size by Application
        3.3.1 United States Cardiovascular and Cerebrovascular API Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Cardiovascular and Cerebrovascular API Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Cardiovascular and Cerebrovascular API Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Cardiovascular and Cerebrovascular API Competitor Landscape by Company
    4.1 Global Cardiovascular and Cerebrovascular API Market Size by Company
        4.1.1 Top Global Cardiovascular and Cerebrovascular API Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Cardiovascular and Cerebrovascular API Revenue by Manufacturer (2017-2022)
        4.1.3 Global Cardiovascular and Cerebrovascular API Sales by Manufacturer (2017-2022)
        4.1.4 Global Cardiovascular and Cerebrovascular API Price by Manufacturer (2017-2022)
    4.2 Global Cardiovascular and Cerebrovascular API Concentration Ratio (CR)
        4.2.1 Cardiovascular and Cerebrovascular API Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cardiovascular and Cerebrovascular API in 2021
        4.2.3 Global Cardiovascular and Cerebrovascular API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Cardiovascular and Cerebrovascular API Manufacturing Base Distribution, Product Type
        4.3.1 Global Cardiovascular and Cerebrovascular API Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Cardiovascular and Cerebrovascular API Product Type
        4.3.3 Date of International Manufacturers Enter into Cardiovascular and Cerebrovascular API Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Cardiovascular and Cerebrovascular API Market Size by Company
        4.5.1 Top Cardiovascular and Cerebrovascular API Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Cardiovascular and Cerebrovascular API Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Cardiovascular and Cerebrovascular API Sales by Players (2020, 2021 & 2022)

 5 Global Cardiovascular and Cerebrovascular API Market Size by Region
    5.1 Global Cardiovascular and Cerebrovascular API Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Cardiovascular and Cerebrovascular API Market Size in Volume by Region (2017-2028)
        5.2.1 Global Cardiovascular and Cerebrovascular API Sales in Volume by Region: 2017-2022
        5.2.2 Global Cardiovascular and Cerebrovascular API Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Cardiovascular and Cerebrovascular API Market Size in Value by Region (2017-2028)
        5.3.1 Global Cardiovascular and Cerebrovascular API Sales in Value by Region: 2017-2022
        5.3.2 Global Cardiovascular and Cerebrovascular API Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Cardiovascular and Cerebrovascular API Market Size YoY Growth 2017-2028
        6.1.2 North America Cardiovascular and Cerebrovascular API Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Cardiovascular and Cerebrovascular API Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Cardiovascular and Cerebrovascular API Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Cardiovascular and Cerebrovascular API Market Size YoY Growth 2017-2028
        6.3.2 Europe Cardiovascular and Cerebrovascular API Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Cardiovascular and Cerebrovascular API Market Size YoY Growth 2017-2028
        6.4.2 Latin America Cardiovascular and Cerebrovascular API Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Cardiovascular and Cerebrovascular API Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Cardiovascular and Cerebrovascular API Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Zhuhai Rundu Pharmaceutical
        7.1.1 Zhuhai Rundu Pharmaceutical Corporation Information
        7.1.2 Zhuhai Rundu Pharmaceutical Description and Business Overview
        7.1.3 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered
        7.1.5 Zhuhai Rundu Pharmaceutical Recent Development
    7.2 Ningbo Menovo Pharmaceutical
        7.2.1 Ningbo Menovo Pharmaceutical Corporation Information
        7.2.2 Ningbo Menovo Pharmaceutical Description and Business Overview
        7.2.3 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered
        7.2.5 Ningbo Menovo Pharmaceutical Recent Development
    7.3 Zhejiang Huahai Pharmaceutical
        7.3.1 Zhejiang Huahai Pharmaceutical Corporation Information
        7.3.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
        7.3.3 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered
        7.3.5 Zhejiang Huahai Pharmaceutical Recent Development
    7.4 Zhejiang Tianyu Pharmaceutical
        7.4.1 Zhejiang Tianyu Pharmaceutical Corporation Information
        7.4.2 Zhejiang Tianyu Pharmaceutical Description and Business Overview
        7.4.3 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered
        7.4.5 Zhejiang Tianyu Pharmaceutical Recent Development
    7.5 Zhejiang Hisun Pharmaceutical
        7.5.1 Zhejiang Hisun Pharmaceutical Corporation Information
        7.5.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
        7.5.3 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered
        7.5.5 Zhejiang Hisun Pharmaceutical Recent Development
    7.6 Zhejiang Lepu Pharmaceutical
        7.6.1 Zhejiang Lepu Pharmaceutical Corporation Information
        7.6.2 Zhejiang Lepu Pharmaceutical Description and Business Overview
        7.6.3 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered
        7.6.5 Zhejiang Lepu Pharmaceutical Recent Development
    7.7 Zhejiang Jiangbei Pharmaceutical
        7.7.1 Zhejiang Jiangbei Pharmaceutical Corporation Information
        7.7.2 Zhejiang Jiangbei Pharmaceutical Description and Business Overview
        7.7.3 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered
        7.7.5 Zhejiang Jiangbei Pharmaceutical Recent Development
    7.8 DR.Reddy
        7.8.1 DR.Reddy Corporation Information
        7.8.2 DR.Reddy Description and Business Overview
        7.8.3 DR.Reddy Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 DR.Reddy Cardiovascular and Cerebrovascular API Products Offered
        7.8.5 DR.Reddy Recent Development
    7.9 Glenmerk
        7.9.1 Glenmerk Corporation Information
        7.9.2 Glenmerk Description and Business Overview
        7.9.3 Glenmerk Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Glenmerk Cardiovascular and Cerebrovascular API Products Offered
        7.9.5 Glenmerk Recent Development
    7.10 Cipla
        7.10.1 Cipla Corporation Information
        7.10.2 Cipla Description and Business Overview
        7.10.3 Cipla Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Cipla Cardiovascular and Cerebrovascular API Products Offered
        7.10.5 Cipla Recent Development
    7.11 MSN Life Sciences
        7.11.1 MSN Life Sciences Corporation Information
        7.11.2 MSN Life Sciences Description and Business Overview
        7.11.3 MSN Life Sciences Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 MSN Life Sciences Cardiovascular and Cerebrovascular API Products Offered
        7.11.5 MSN Life Sciences Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Cardiovascular and Cerebrovascular API Industry Chain Analysis
    8.2 Cardiovascular and Cerebrovascular API Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Cardiovascular and Cerebrovascular API Distributors
    8.3 Cardiovascular and Cerebrovascular API Production Mode & Process
    8.4 Cardiovascular and Cerebrovascular API Sales and Marketing
        8.4.1 Cardiovascular and Cerebrovascular API Sales Channels
        8.4.2 Cardiovascular and Cerebrovascular API Distributors
    8.5 Cardiovascular and Cerebrovascular API Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Cardiovascular and Cerebrovascular API CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Cardiovascular and Cerebrovascular API Market Trends
    Table 3. Cardiovascular and Cerebrovascular API Market Drivers
    Table 4. Cardiovascular and Cerebrovascular API Market Challenges
    Table 5. Cardiovascular and Cerebrovascular API Market Restraints
    Table 6. Global Cardiovascular and Cerebrovascular API Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cardiovascular and Cerebrovascular API Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cardiovascular and Cerebrovascular API Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cardiovascular and Cerebrovascular API Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cardiovascular and Cerebrovascular API Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cardiovascular and Cerebrovascular API Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Cardiovascular and Cerebrovascular API Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Cardiovascular and Cerebrovascular API Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Cardiovascular and Cerebrovascular API Sales Share by Manufacturer, 2017-2022
    Table 15. Global Cardiovascular and Cerebrovascular API Price by Manufacturer (2017-2022) & (USD/Kg)
    Table 16. Global Cardiovascular and Cerebrovascular API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Cardiovascular and Cerebrovascular API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular and Cerebrovascular API as of 2021)
    Table 18. Top Players of Cardiovascular and Cerebrovascular API in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Cardiovascular and Cerebrovascular API Product Type
    Table 20. Date of International Manufacturers Enter into Cardiovascular and Cerebrovascular API Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Cardiovascular and Cerebrovascular API Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Cardiovascular and Cerebrovascular API Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Cardiovascular and Cerebrovascular API Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Cardiovascular and Cerebrovascular API Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Cardiovascular and Cerebrovascular API Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Cardiovascular and Cerebrovascular API Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Cardiovascular and Cerebrovascular API Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Cardiovascular and Cerebrovascular API Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Cardiovascular and Cerebrovascular API Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Cardiovascular and Cerebrovascular API Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Cardiovascular and Cerebrovascular API Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Cardiovascular and Cerebrovascular API Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Cardiovascular and Cerebrovascular API Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Cardiovascular and Cerebrovascular API Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Cardiovascular and Cerebrovascular API Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Cardiovascular and Cerebrovascular API Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Cardiovascular and Cerebrovascular API Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Cardiovascular and Cerebrovascular API Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Cardiovascular and Cerebrovascular API Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Cardiovascular and Cerebrovascular API Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Zhuhai Rundu Pharmaceutical Corporation Information
    Table 43. Zhuhai Rundu Pharmaceutical Description and Business Overview
    Table 44. Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 45. Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Product
    Table 46. Zhuhai Rundu Pharmaceutical Recent Development
    Table 47. Ningbo Menovo Pharmaceutical Corporation Information
    Table 48. Ningbo Menovo Pharmaceutical Description and Business Overview
    Table 49. Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 50. Ningbo Menovo Pharmaceutical Product
    Table 51. Ningbo Menovo Pharmaceutical Recent Development
    Table 52. Zhejiang Huahai Pharmaceutical Corporation Information
    Table 53. Zhejiang Huahai Pharmaceutical Description and Business Overview
    Table 54. Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 55. Zhejiang Huahai Pharmaceutical Product
    Table 56. Zhejiang Huahai Pharmaceutical Recent Development
    Table 57. Zhejiang Tianyu Pharmaceutical Corporation Information
    Table 58. Zhejiang Tianyu Pharmaceutical Description and Business Overview
    Table 59. Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 60. Zhejiang Tianyu Pharmaceutical Product
    Table 61. Zhejiang Tianyu Pharmaceutical Recent Development
    Table 62. Zhejiang Hisun Pharmaceutical Corporation Information
    Table 63. Zhejiang Hisun Pharmaceutical Description and Business Overview
    Table 64. Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 65. Zhejiang Hisun Pharmaceutical Product
    Table 66. Zhejiang Hisun Pharmaceutical Recent Development
    Table 67. Zhejiang Lepu Pharmaceutical Corporation Information
    Table 68. Zhejiang Lepu Pharmaceutical Description and Business Overview
    Table 69. Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 70. Zhejiang Lepu Pharmaceutical Product
    Table 71. Zhejiang Lepu Pharmaceutical Recent Development
    Table 72. Zhejiang Jiangbei Pharmaceutical Corporation Information
    Table 73. Zhejiang Jiangbei Pharmaceutical Description and Business Overview
    Table 74. Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 75. Zhejiang Jiangbei Pharmaceutical Product
    Table 76. Zhejiang Jiangbei Pharmaceutical Recent Development
    Table 77. DR.Reddy Corporation Information
    Table 78. DR.Reddy Description and Business Overview
    Table 79. DR.Reddy Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 80. DR.Reddy Product
    Table 81. DR.Reddy Recent Development
    Table 82. Glenmerk Corporation Information
    Table 83. Glenmerk Description and Business Overview
    Table 84. Glenmerk Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 85. Glenmerk Product
    Table 86. Glenmerk Recent Development
    Table 87. Cipla Corporation Information
    Table 88. Cipla Description and Business Overview
    Table 89. Cipla Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 90. Cipla Product
    Table 91. Cipla Recent Development
    Table 92. MSN Life Sciences Corporation Information
    Table 93. MSN Life Sciences Description and Business Overview
    Table 94. MSN Life Sciences Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 95. MSN Life Sciences Product
    Table 96. MSN Life Sciences Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Cardiovascular and Cerebrovascular API Customers List
    Table 100. Cardiovascular and Cerebrovascular API Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cardiovascular and Cerebrovascular API Product Picture
    Figure 2. Global Cardiovascular and Cerebrovascular API Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cardiovascular and Cerebrovascular API Market Size 2017-2028 (US$ Million)
    Figure 4. Global Cardiovascular and Cerebrovascular API Sales 2017-2028 (MT)
    Figure 5. United States Cardiovascular and Cerebrovascular API Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Cardiovascular and Cerebrovascular API Market Size 2017-2028 (US$ Million)
    Figure 7. United States Cardiovascular and Cerebrovascular API Sales 2017-2028 (MT)
    Figure 8. United States Cardiovascular and Cerebrovascular API Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Cardiovascular and Cerebrovascular API Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Cardiovascular and Cerebrovascular API Report Years Considered
    Figure 11. Product Picture of Sartans Cardiovascular and Cerebrovascular API
    Figure 12. Product Picture of Statins Cardiovascular and Cerebrovascular API
    Figure 13. Product Picture of Puri Cardiovascular and Cerebrovascular API
    Figure 14. Global Cardiovascular and Cerebrovascular API Market Share by Type in 2022 & 2028
    Figure 15. Global Cardiovascular and Cerebrovascular API Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Cardiovascular and Cerebrovascular API Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Cardiovascular and Cerebrovascular API Sales by Type (2017-2028) & (MT)
    Figure 18. Global Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Cardiovascular and Cerebrovascular API Price by Type (2017-2028) & (USD/Kg)
    Figure 20. United States Cardiovascular and Cerebrovascular API Market Share by Type in 2022 & 2028
    Figure 21. United States Cardiovascular and Cerebrovascular API Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Cardiovascular and Cerebrovascular API Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Cardiovascular and Cerebrovascular API Sales by Type (2017-2028) & (MT)
    Figure 24. United States Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Cardiovascular and Cerebrovascular API Price by Type (2017-2028) & (USD/Kg)
    Figure 26. Product Picture of Oral Drugs
    Figure 27. Product Picture of Injection Drugs
    Figure 28. Global Cardiovascular and Cerebrovascular API Market Share by Application in 2022 & 2028
    Figure 29. Global Cardiovascular and Cerebrovascular API Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Cardiovascular and Cerebrovascular API Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Cardiovascular and Cerebrovascular API Sales by Application (2017-2028) & (MT)
    Figure 32. Global Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Cardiovascular and Cerebrovascular API Price by Application (2017-2028) & (USD/Kg)
    Figure 34. United States Cardiovascular and Cerebrovascular API Market Share by Application in 2022 & 2028
    Figure 35. United States Cardiovascular and Cerebrovascular API Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Cardiovascular and Cerebrovascular API Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Cardiovascular and Cerebrovascular API Sales by Application (2017-2028) & (MT)
    Figure 38. United States Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Cardiovascular and Cerebrovascular API Price by Application (2017-2028) & (USD/Kg)
    Figure 40. North America Cardiovascular and Cerebrovascular API Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 41. North America Cardiovascular and Cerebrovascular API Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Cardiovascular and Cerebrovascular API Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 45. Europe Cardiovascular and Cerebrovascular API Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Cardiovascular and Cerebrovascular API Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 52. Asia-Pacific Cardiovascular and Cerebrovascular API Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. China Taiwan Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Cardiovascular and Cerebrovascular API Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 63. Latin America Cardiovascular and Cerebrovascular API Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Cardiovascular and Cerebrovascular API Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 68. Middle East & Africa Cardiovascular and Cerebrovascular API Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Cardiovascular and Cerebrovascular API Value Chain
    Figure 73. Cardiovascular and Cerebrovascular API Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed

Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.

Market Analysis and Insights: Global and United States Cardiovascular and Cerebrovascular API Market
This report focuses on global and United States Cardiovascular and Cerebrovascular API market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Cardiovascular and Cerebrovascular API market size is estimated to be worth US$ 3162.7 million in 2022 and is forecast to a readjusted size of US$ 3710.9 million by 2028 with a CAGR of 2.7% during the review period. Fully considering the economic change by this health crisis, by Type, Sartans Cardiovascular and Cerebrovascular API accounting for % of the Cardiovascular and Cerebrovascular API global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Oral Drugs was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

China is the main production area of cardiovascular and cerebrovascular raw materials, with a market share of more than 65%, followed by India and Europe.

The key manufacturers are Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, MSN Life Sciences etc. Zhejiang Huahai Pharmaceutical Co., Ltd. is the largest producer of cardiovascular and cerebrovascular raw materials in China region market and global market, accounting for more than 10%.

Global Cardiovascular and Cerebrovascular API Scope and Market Size
Cardiovascular and Cerebrovascular API market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cardiovascular and Cerebrovascular API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Cardiovascular and Cerebrovascular API market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Cardiovascular and Cerebrovascular API market is segmented into
    Sartans Cardiovascular and Cerebrovascular API
    Statins Cardiovascular and Cerebrovascular API
    Puri Cardiovascular and Cerebrovascular API

Segment by Application, the Cardiovascular and Cerebrovascular API market is segmented into
    Oral Drugs
    Injection Drugs

Regional and Country-level Analysis
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Cardiovascular and Cerebrovascular API Market Share Analysis
Cardiovascular and Cerebrovascular API market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Cardiovascular and Cerebrovascular API business, the date to enter into the Cardiovascular and Cerebrovascular API market, Cardiovascular and Cerebrovascular API product introduction, recent developments, etc.

The major vendors covered:
    Zhuhai Rundu Pharmaceutical
    Ningbo Menovo Pharmaceutical
    Zhejiang Huahai Pharmaceutical
    Zhejiang Tianyu Pharmaceutical
    Zhejiang Hisun Pharmaceutical
    Zhejiang Lepu Pharmaceutical
    Zhejiang Jiangbei Pharmaceutical
    DR.Reddy
    Glenmerk
    Cipla
    MSN Life Sciences